ABBV

REGENXBIO maps 2026 gene therapy milestones
Gene therapy developer eyes pivotal muscle and retinal readouts next year, but faces tumor-linked regulatory setbacks.
Mar 6, 2026
6 min read
Boston Scientific, AbbVie, NOG Lead Busy Corporate Day
Boston Scientific boosts buybacks; AbbVie invests $380M in new plants; NOG and KDP make strategic moves.
Feb 23, 2026
4 min read
Christmas Eve early close shapes U.S. markets
Markets brace for early close amid thin liquidity; focus on jobless claims and sector-specific trends.
Dec 24, 2025
8 min read
Lam Research, Broadcom, Oracle Lead Q3 Growth Amid AI Demand
Lam Research, Broadcom, and Oracle drive Q3 growth with strong AI demand and major contracts.
Nov 12, 2025
6 min read